Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Unani medicine may help treat a rare, hard-to-treat hair loss pattern in children.

64 drugs can cause hair loss, needing better monitoring and updated labels.

Alopesi tedavisinde ilaçlar saç büyümesini teşvik eder ve yeni yaklaşımlar umut vaat eder.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

The SAALIQ is a reliable tool for measuring the impact of alopecia areata on Spanish-speaking patients' quality of life.

Understanding different types of hair loss helps in accurate diagnosis and treatment.

Tofacitinib is effective and safe for treating severe alopecia areata.

Peptides improve skin health and treatments for hair loss and pregnancy-related skin issues are evolving.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Recognizing and treating related skin conditions can improve atopic dermatitis management.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

Topical immunotherapy can help with severe hair loss, but results vary and need personalized, long-term treatment.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Consider cultural practices and barriers for effective alopecia areata treatment.

Ongoing research and innovation are crucial for improving skin care and treatment.

Nursing care is crucial for safe and effective hair transplants.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Proactive physical therapy improved mobility, reduced fatigue, and pain in lupus patients.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

Anti-CD19 therapy may help treat SLE and NMOSD.

Early recognition and management of gastrointestinal tuberculosis in lupus patients are crucial to prevent complications.

Catatonia can be a rare sign of lupus, needing careful diagnosis and treatment.

Purpura fulminans can signal underlying autoimmune disorders, not just infections.